These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 3509513)
1. Therapeutic trials with HPA23, alpha-IFN and ribavirin in AIDS patients. Moroni M; Lazzarin A; Orlando G; Crocchiolo P; Castagna A; Verani P Chemioterapia; 1987 Jun; 6(2 Suppl):639-41. PubMed ID: 3509513 [No Abstract] [Full Text] [Related]
2. Antiviral drugs for AIDS. Current status and future prospects. Sandström E Drugs; 1986 Jun; 31(6):463-6. PubMed ID: 2942386 [No Abstract] [Full Text] [Related]
3. Progress in the development of antiviral therapy for HTLV-III-associated diseases. Yarchoan R; Broder S Important Adv Oncol; 1987; ():293-311. PubMed ID: 2841232 [No Abstract] [Full Text] [Related]
4. [Experimental chemotherapy of AIDS]. Rada B Cas Lek Cesk; 1988 May; 127(22):677-83. PubMed ID: 3293790 [No Abstract] [Full Text] [Related]
5. Immunologic reconstitution in the acquired immunodeficiency syndrome. Lane HC; Fauci AS Ann Intern Med; 1985 Nov; 103(5):714-8. PubMed ID: 2996405 [TBL] [Abstract][Full Text] [Related]
6. Anti-AIDS agents show varying early results in vitro and in vivo. Riesenberg DE; Marwick C JAMA; 1985 Nov; 254(18):2521, 2527, 2529. PubMed ID: 2997490 [No Abstract] [Full Text] [Related]
8. Prospects of therapy for infections with human T-lymphotropic virus type III. Hirsch MS; Kaplan JC Ann Intern Med; 1985 Nov; 103(5):750-5. PubMed ID: 2413793 [TBL] [Abstract][Full Text] [Related]
9. R-interferon alpha A and suramin sodium in the treatment of AIDS and ARC cases. Raise E; Gritti FM; Bonazzi L; Monti M; Grillo A; Savoia M; Gambetti M; Pulsatelli L; Casertano MG; Di Figlia C J Exp Pathol; 1987; 3(4):737-43. PubMed ID: 3454811 [No Abstract] [Full Text] [Related]
10. A trial with ribavirin in patients with AIDS or AIDS-related complex. Crocchiolo P; Pristera R; Lazzarin A; Chemotti M; Froldi M; Palazzini E; Verani P; Orecchia A; Moroni M Boll Ist Sieroter Milan; 1989; 68(2):185-90. PubMed ID: 2491303 [TBL] [Abstract][Full Text] [Related]
11. Reverse transcriptase activity (RTA) in lymphocyte cultures of HIV-infected patients receiving short treatments of HPA 23. A biological evaluation. Vittecoq D; Woerle R; Barre-Sinoussi F; Chermann JC Biomed Pharmacother; 1988; 42(1):35-9. PubMed ID: 2457397 [TBL] [Abstract][Full Text] [Related]
12. Ammonium-5-tungsto-2-antimoniate (HPA23) can prevent fox rabies. Pepin M; Blancou J Arch Virol; 1985; 83(3-4):327-9. PubMed ID: 3970678 [TBL] [Abstract][Full Text] [Related]
13. Ribavirin treatment of the acquired immunodeficiency syndrome (AIDS) and the acquired-immunodeficiency-syndrome-related complex (ARC). A phase 1 study shows transient clinical improvement associated with suppression of the human immunodeficiency virus and enhanced lymphocyte proliferation. Crumpacker C; Heagy W; Bubley G; Monroe JE; Finberg R; Hussey S; Schnipper L; Lucey D; Lee TH; McLane MF Ann Intern Med; 1987 Nov; 107(5):664-74. PubMed ID: 3662279 [TBL] [Abstract][Full Text] [Related]
14. Antiviral therapy in AIDS. Clinical pharmacological properties and therapeutic experience to date. Sandström EG; Kaplan JC Drugs; 1987 Sep; 34(3):372-90. PubMed ID: 2824170 [TBL] [Abstract][Full Text] [Related]
15. [Antiviral agents and AIDS]. Hanc O Cesk Farm; 1989 Feb; 38(1):29-35. PubMed ID: 2743428 [No Abstract] [Full Text] [Related]
16. Antimoniotungstate (HPA 23) treatment of three patients with AIDS and one with prodrome. Rozenbaum W; Dormont D; Spire B; Vilmer E; Gentilini M; Griscelli C; Montagnier L; Barre-Sinoussi F; Chermann JC Lancet; 1985 Feb; 1(8426):450-1. PubMed ID: 2857819 [No Abstract] [Full Text] [Related]
17. Treatment of rabies in mice and foxes with antiviral compounds. Bussereau F; Picard M; Blancou J; Sureau P Acta Virol; 1988 Jan; 32(1):33-49. PubMed ID: 2897770 [TBL] [Abstract][Full Text] [Related]
18. AIDS drug gets green light. Ezzell C Nature; 1987 Oct 29-Nov 4; 329(6142):751. PubMed ID: 3670377 [No Abstract] [Full Text] [Related]
19. Chemotherapeutic approach of AIDS. De Clercq E Verh K Acad Geneeskd Belg; 1988; 50(2):166-217. PubMed ID: 3064481 [No Abstract] [Full Text] [Related]
20. The antiviral effect of zidovudine and ribavirin in clinical trials and the use of p24 antigen levels as a virologic marker. Spector SA; Kennedy C; McCutchan JA; Bozzette SA; Straube RG; Connor JD; Richman DD J Infect Dis; 1989 May; 159(5):822-8. PubMed ID: 2496173 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]